Contactos
Dirección
Argentina, Buenos Aires , Pilar, Calle 9 Ing. Meyer Oks No 593
Teléfonos de empresa
Dirección
+54
Al pedir, informe al administrador que la información la supo en Allbiz. ¡Le agradecemos que compra con Allbiz!
Internet
La página Web:
Sobre empresa
Glenmark Generics Argentina, S.A.
Glenmark Generics Argentina is the hub for generic research, manufacturing and distribution of oncology products for the whole world. This process started with the acquisition of an Argentine oncology company, Servycal S.A. in 2005 by Glenmark. The company’s continuous growth since then now spans 23 countries. Our team of qualified professionals, pharmacists and physicians has helped position the company as an important player in oncology in Latin and Central America. This process continues, as the company looks to become a global leader in oncology in the future. Our people, our stringent quality standards and our vision for a healthier world explain the substantial growth Glenmark Generics has experienced in a short time. It has also helped position us as a specialist in cancer care.
Solutions for a growing problem – The incidence of cancer in the world
Oncology is a specific area which has a major share of the public tender market in most of the countries serviced by Glenmark Generics. The public spending on oncology constitute to around 60% of the total oncology market in most of the developing markets. Cancer as a disease process has had a huge rise in incidence in the last decade. The rise of incidence has been attributed not only to the changing lifestyles of the population across the globe but also to the increasing access to public healthcare.
The portfolio of Glenmark covers a wide range of generic oncology products which cater to around 75% of all cancers. In the first half of 2007 alone, the company has done 44 launches across 10 markets.
Disponibles
Letrozole is indicated for the treatment of advanced breast cancer in women in the postmenopausal stage, whether natural or artificially induced, with disease progression or recurrence following antiestrogen therapy.
Grupo: Preparaciones hormonales
Disponibles
ATC classification: H01C B01
This hormone inhibits the:
Secretion of hydrochloric acid and pepsin, and gastrin release.
Pancreatic exocrine secretion.
Stimulated release of secretin and pancreozymin.
Besides, the perfusion of Somatostatin has shown to decrease splanchnic flow up to a 30% with...
Grupo: Agentes para el tratamiento de las hemorroides
Disponibles
Leucovorin calcium rescue is indicated after high dose methotrexate therapy in osteosarcoma.
It is also indicated to diminish the toxicity and counteract the toxic effects due to methotrexate elimination and in cases of inadvertent overdosages of folic acid antagonists.
It is indicated in the...
Grupo: Medicamentos
Disponibles
Acido zoledrónico monohidratado (equiv.
a 4,00 mg de ácido zoledrónico anhidro) 4,264 mg.
Manitol 220,000 mg.
Citrato de sodio 24,000 mg. El ácido zoledrónico está indicado en el tratamiento de la hipercalcemia inducida por tumor. Una vigorosa hidratación salina y una terapia para...
Grupo: Medicamentos
Disponibles
Each vial of Cisplatino Servycal 10 mg contains:
Cisplatin 10mg
Mannitol 100 mg
Sodium chloride 90 mg
Hydrochloric acid q.s. to adjust pH 3.4
Each vial of Cisplatino Servycal 50 mg contains:
Cisplatin 50 mg
Mannitol 500 mg
Sodium chloride 450 mg
Hydrochloric acid q.s. to adjust pH 3.4
Grupo: Medicamentos genéricos
Disponibles
Successful results were achieved in tha application of DOXORUBICIN to produce a regression in disseminated neoplastic diseases such as lymphoblastic leukemia, acute myeloblastic leukemia, Tumor Wilms, neuroblastoma, soft tissue sarcoma and osteosarcoma, breast carcinoma, ovarian carcinoma,...
Grupo: Preparados oncologos
Disponibles
Ondansetron (como clorhidrato dihidrato) 4,00 mg. 8,00 mg.
Acido cítrico anhidro 0,91 mg. 1,82 mg.
Citrato de sodio dihidrato 0,57 mg. 1,14 mg.
Cloruro de sodio 18,00 mg. 36,00 mg.
Agua destilada estéril para inyectables c.s.p. 2,00 ml. 4,00 ml.
Este medicamento está indicado:
1....
Grupo: Medicamentos para el tratamiento del aparato digestivo
Disponibles
Oxaliplatin 50 mg
Mannitol USP 200 mg
Treatment of metastatic colorectal cancer after previous treatment with fluoropyrimidines in monochemotherapy or combination chemotherapy.
Grupo: Preparados para la inyección
Disponibles
Ifosfamide is used in combination with other approved antineoplasic agents.
It is indicated in second and third line chemotherapy of germinal cell testicular cancer.
It must be used in combination with a prophylactic agent for hemorrhagic cystitis such as mesna
Presentation:
Ifosfamida...
Grupo: Agentes antineoplásicos
Disponibles
Carboplatino Servycal is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other chemotherapeutic agents. One established combination regime consists of Carboplatino Servycal and cyclophosphamide. Two randomized controlled studies carried out by the...
Grupo: Medicamentos